Latest News May 13, 2026 Esperion Announces Two New Analyses Supporting Bempedoic Acid to Reduce LDL-C Levels to be Presented at the European Atherosclerosis Society (EAS) Congress 2026 May 01, 2026 Esperion to be Acquired by ARCHIMED View All News Latest Quarterly Earnings Results Corporate Presentation ESPR Company Presentation - March 2026 6.6 MB Investor Events Upcoming Events May 28, 2026 8:00 AM EDT Esperion Therapeutics, Inc. 2026 Annual Meeting of Stockholders Past Events Apr 13, 2026 9:30 AM EDT 25th Annual Needham Virtual Healthcare Conference Mar 11, 2026 8:25 AM EDT The 2026 Citizens Life Sciences Conference View All Events
May 13, 2026 Esperion Announces Two New Analyses Supporting Bempedoic Acid to Reduce LDL-C Levels to be Presented at the European Atherosclerosis Society (EAS) Congress 2026